Responses
Clinical and epidemiological research
Extended report
Long-term safety and efficacy of certolizumab pegol in combination with methotrexate in the treatment of rheumatoid arthritis: 5-year results from the RAPID 1 trial and open-label extension
Compose a Response to This Article
Other responses
No responses have been published for this article.